Fonte: Fortune
A clinical trial failure and U. S. competition have been tough for the Danish pharmaceutical firm.
Ler na Fonte
Notícias Relacionadas
Lista de Notícias
Weight loss drug Wegovy made Novo Nordisk Europe’s most valuable company. Finding its next blockbuster drug is proving difficult
Weight
Fortune
há 10h
